Acting for ProfoundBio Inc. in its US$1.8 billion acquisition by Genmab A/S (NASDAQ: GMAB)

Cayman Islands counsel to ProfoundBio Inc., which was acquired in May 2024 by international biotechnology company Genmab by way of Cayman Islands merger. Lucy Anderson led our team.